Mammary Analogue Secretory Carcinoma of the Soft Palate: A Report of Two Cases

Denrick Cooper, Brian Burkey, Deborah Chute, Joseph Scharpf

Department of Anatomic Pathology, Cleveland Clinic, Cleveland, USA.
Department of Otolaryngology, Head and Neck Surgery, Cleveland Clinic, Cleveland, USA.

DOI: 10.4236/ijohns.2013.25037                

Abstract

Mammary analogue secretory carcinoma (MASC) is a recently identified salivary tumor that shares morphological features of secretory carcinoma of the breast, salivary acinic cell carcinoma, low grade cystadenocarcinoma and mucoepidermoid carcinoma. To date, a majority of cases have been reported in the major salivary glands with very few seen in the palate. We present 2 single institution cases of MASC of the soft palate to help further characterize this novel tumor.

Keywords

Mammary Analogue Secretory Carcinoma; ETV6-NTRK3; Secretory Carcinoma

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	D. M. Parkin, J. Ferlay, M. P. Curado, et al., “Fifty Years of Cancer Incidence: CI5 I-IX,” International Journal of Cancer, Vol. 127, No. 12, 2010, pp. 2918-2927. doi:10.1002/ijc.25517
[2]	L. A. G. Ries, B. F. Hankey, B. A. Miller, et al., “Cancer Statistics Review 1973-88,” National Cancer Institute, Bethesda, 1991.
[3]	C. Tognon, S. R. Knezevich, D. Huntsman, et al., “Expression of the ETV6-NTRK3 Gene Fusion as a Primary Event in Human Secretory Breast Carcinoma,” Cancer Cell, Vol. 2, No. 5, 2002, pp. 367-376. doi:10.1016/S1535-6108(02)00180-0
[4]	S. I. Chiosea, et al., “The Profile of Acinic Cell Carcinoma after Recognition of Mammary Analog Secretory Carcinoma,” American Journal of Surgical Pathology, Vol. 36, No. 3, 2012, pp. 343-350. doi:10.1097/PAS.0b013e318242a5b0
[5]	A. Skalova, T. Vanecek, R. Sima, et al., “Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity,” American Journal of Surgical Pathology, Vol. 34, No. 5, 2010, pp. 599-608. doi:10.1097/PAS.0b013e3181d9efcc
[6]	F. J. Kratochvil 3rd, J. C. Stewart and S. R. Moore, “Mammary Analog Secretory Carcinoma of Salivary Glands: A Report of 2 Cases in the Lips,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Vol. 114, No. 5, 2012, pp. 630-635. doi:10.1016/j.oooo.2012.07.480
[7]	S. I. Chiosea, C. Griffith, A. Assaad and R. R. Seethala, “Clinicopathological Characterization of Mammary Analogue Secretory Carcinoma of Salivary Glands,” Histopathology, Vol. 61, No. 3, 2012, pp. 387-394. doi:10.1111/j.1365-2559.2012.04232.x
[8]	A. Fehr, T. Loning and G. Stenman, “Mammary Analogue Secretory Carcinoma of the Salivary Glands with ETV6-NTRK3 Gene Fusion,” American Journal of Surgical Pathology, Vol. 35, No. 10, 2011, pp. 1600-1602. doi:10.1097/PAS.0b013e31822832c7
[9]	F. Petersson, D. Lian, Y. P. Chau and B. Yan, “Mammary Analogue Secretory Carcinoma: The First Submandibular Case Reported Including Findings on Fine Needle Aspiration Cytology,” Head and Neck Pathology, Vol. 6, No. 1, 2012, pp. 135-139. doi:10.1007/s12105-011-0283-x
[10]	L. Pisharodi, “Mammary Analog Secretory Carcinoma of Salivary Gland: Cytologic Diagnosis and Differential Diagnosis of an Unreported Entity,” Diagnostic Cytopathology, Vol. 41, No. 3, 2012, pp. 239-243. doi:10.1002/dc.21766
[11]	S. Ito, E. Ishida, A. Skalova, K. Matsuura, H. Kumamoto and I. Sato, “Case Report of Mammary Analog Secretory Carcinoma of the Parotid Gland,” Pathology International, Vol. 62, No. 2, 2012, pp. 149-152. doi:10.1111/j.1440-1827.2011.02759.x
[12]	J. C. Rastatter, K. R. Jatana, L. J. Jennings and H. MelinAldana, “Mammary Analogue Secretory Carcinoma of the Parotid Gland in a Pediatric Patient, Otolaryngology —Head and Neck Surgery, Vol. 146, No. 3, 2012, pp. 514-515. doi:10.1177/0194599811419044
[13]	S. D. Vincent, H. L. Hammond and M. W. Finkelstein, “Clinical and Therapeutic Features of Polymorphous LowGrade Adenocarcinoma,” Oral Surgery, Oral Medicine, Oral Pathology, Vol. 77, No. 1, 1994, pp. 41-47. doi:10.1016/S0030-4220(06)80105-2
[14]	R. González-García, F. J. Rodríguez-Campo, M. F. Munoz-Guerra, S. H. Nam-Cha, J. Sastre-Pérez and L. Naval-Gías, “Polymorphous Low-Grade Adenocarcinoma of the Palate: Report of Cases,” Auris, Nasus, Larynx, Vol. 32, No. 3, 2005, p. 275. doi:10.1016/j.anl.2005.03.019
[15]	J. T. Castle, L. D. Thompson, R. A. Frommelt, B. M. Wenig and H. P. Kessler, “Polymorphous Low Grade Adenocarcinoma,” Cancer, Vol. 86, No. 2, 1999, pp. 207-219. doi:10.1002/(SICI)1097-0142(19990715)86:2<207::AID-CNCR4>3.0.CO;2-Q
[16]	I. A. El-Naaj, Y. Leiser, A. Wolff and M. Peled, “Polymorphous Low Grade Adenocarcinoma: Case Series and Review of Surgical Management,” Journal of Oral and Maxillofacial Surgery, Vol. 69, No. 7, 2011, pp. 1967-1972. doi:10.1016/j.joms.2010.10.010
[17]	M. Brandwein-Gensler and D. R. Gnepp, “Low-Grade Cribriform Cystadenocarcinoma,” World Health Organization Classification of Tumours, Pathology & Genetics, Head and Neck Tumours, 2005.
[18]	L. Wang, Y. Liu, X. Lin, D. Zhang, Q. Li, X. Qiu and E. H. Wang, “Low-Grade Cribriform Cystadenocarcinoma of Salivary Glands: Report of Two Cases and Review of the Literature,” Diagnostic Pathology, Vol. 8, No. 1, 2013, pp. 1-6. doi:10.1186/1746-1596-8-28